Gyre Therapeutics GYRE
NASDAQ GYRE
$7.33 +0.01 (+0.14%)
At close: Sep 30, 2026 · 4:00 PM EDT

Gyre Therapeutics (GYRE) Total Liabilities (2010 - 2026)

Updated

Gyre Therapeutics' Total Liabilities was $56.77 million in Q2 2026, down 39.0% from $93.04 million a year earlier and down 52.3% from the prior quarter.

Analysis

Gyre Therapeutics (GYRE) Total Liabilities (2010 - 2026) Analysis & Trends

At the end of FY2025, Total Liabilities at Gyre Therapeutics came in at $157.27 million, up 75.5% from FY2024.

  • Total Liabilities shows a five-year compound annual growth rate of 53.0% (FY2020 to FY2025).
  • In earlier years, Total Liabilities was $89.62 million in FY2024 (-12.6%), $102.59 million in FY2023 (+718.4%), $12.54 million in FY2022 and -$3.8 million in FY2021.
  • Quarterly Total Liabilities has moved between -$75.35 million (Q3 2023) and $157.27 million (Q4 2025) over five years.
  • Compared with a year earlier, Total Liabilities was higher in four of the last seven quarters, with growth averaging 63.5%.
  • The best year-over-year quarter for Total Liabilities over five years was Q4 2023 (growth of 718.4%); the worst was Q3 2022 (a decline of 90.8%).
  • Per Business Quant data, GYRE's Total Liabilities in the three quarters before Q2 2026 was $118.93 million (Q1 2026), $157.27 million (Q4 2025) and $21.97 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 116.09 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 141.05 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 87.82 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 80.09 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 65.46 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 83.95 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 37.53 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 115.64 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 7.18 Bn
10 Gyre Therapeutics 777.23 Mn 579.94 Mn 26.90 Mn 56.77 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 56.77 Mn
Mar 31, 2026 118.93 Mn
Dec 31, 2025 157.27 Mn
Sep 30, 2025 21.97 Mn
Jun 30, 2025 93.04 Mn
Mar 31, 2025 89.12 Mn
Dec 31, 2024 89.62 Mn
Sep 30, 2024 26.77 Mn
Jun 30, 2024 27.58 Mn
Mar 31, 2024 33.24 Mn
Dec 31, 2023 102.59 Mn
Sep 30, 2023 -75.35 Mn
Jun 30, 2023 -65.07 Mn
Mar 31, 2023 -58.58 Mn
Dec 31, 2022 12.54 Mn
Sep 30, 2022 1.64 Mn
Jun 30, 2022 4.31 Mn
Mar 31, 2022 13.19 Mn
Dec 31, 2021 -3.80 Mn
Sep 30, 2021 17.80 Mn
API Access

Gyre Therapeutics Total Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-liabilities&ticker=GYRE&period=max&api_key=YOUR_API_KEY